Replies to post #2475 on AVEO Pharmaceuticals, Inc. (AVEO)

[alexander77]

Look to the history of different biotech companies: all dilute before bad news.
If they would expect the news was good, they would have gotten the same amount of money without diluting this many shares.
If yhe expect the news is bad, they dilute before news, because other wise the share price implodes and it gets much more difficult to raise capital.

It is going to be bad news from EMA. IMO.